July 12, 2014 10:57 AM ET

Biotechnology

Company Overview of Immunex Corporation

Company Overview

As of July 15, 2002, Immunex Corporation was acquired by Amgen, Inc. Immunex Corporation researches, develops, manufacturers, and markets therapeutic products for the treatment of cancer, infectious diseases, and autoimmune disorders. It offers products, such as Enbrel that is used in the treatment of rheumatoid arthritis; Novantrone, which is used to treat acute nonlymphocytic leukemia and pain associated with prostate cancer; and Leukine for use in bone marrow transplant patients. The company has franchise operations. It has a strategic alliance with American Home Products. The company was founded in 1981 and is based in Seattle, Washington.

51 University Street

Seattle, WA 98101

United States

Founded in 1981

1,618 Employees

Phone:

206-587-0430

Fax:

206-587-0606

Key Executives for Immunex Corporation

Immunex Corporation does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Nittobo America Incorporated United States
Vectoris Pharma LLC United States
Aridis Pharmaceuticals, LLC United States
Halcyon Molecular, Inc. United States
VICAM LP United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Immunex Corporation, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.